Hims & Hers Health, Inc. (HIMS)

NYQ – Real Time Price. Currency in USD

29.98

-0.53 (-1.74%)

At close: Aug 12, 2026, 3:59 PM EDT

29.97

+0.00 (0.00%)

After-hours: Aug 12, 2026, 4:57 PM EDT

12.08.2026

NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

RADNOR, Pa., Aug. 12, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. securities and experienced significant financial losses.

12.08.2026

As Hims prepares for peptides launch, Wall Street cautious on prospects this year

Hims & Hers Health plans to offer some legally available peptides in 2026, but investors and analysts who spoke to Reuters after the telehealth company's quarterly results this week said sales for that offering are unlikely to ‌drive revenue growth this year.

12.08.2026

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES, Aug. 12, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) on behalf of investors concerning the Company's possible violations of federal securities laws.

12.08.2026

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - August 12, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Hims & Hers investor and have suffered losses, or if you have information that could assist in the Hims & Hers investigation, you may CLICK HERE to contact us.

12.08.2026

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)

PHILADELPHIA, Aug. 12, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE: HIMS) ("Hims & Hers" or the "Company") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigation is focused on whether the Company improperly shared private user health data with advertisers, engaged in deceptive billing practices, and made subscription cancellations unnecessarily difficult.

12.08.2026

Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem

Hims & Hers Health delivered strong Q2 2026 revenue growth but suffered margin compression and negative free cash flow. I rate HIMS a Sell, as the raised revenue guidance is offset by declining gross margins and a stagnant adjusted EBITDA outlook. The shift to branded GLP-1 weight-loss drugs and international expansion are driving higher costs and complicating the profitability story.

11.08.2026

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C. (“Lowey”) announces that it filed the first class action complaint against Hims & Hers Health, Inc. (“Hims & Hers”) on behalf of consumers of the Hims & Hers telehealth platforms—one day after the Federal Trade Commission (“FTC”), joined by the People of the State of California and the Utah Division of Consumer Protection, filed its civil enforcement action against the company.

Videos

11.08.2026

Negative

Tuesday's Morning Movers: RKLB & HIMS Earnings, RIOT Gets Anthropic Deal

10.08.2026

Positive

Raul Shah on HIMS Earnings Expectations & GLP-1 Wave's Lasting Stock Impacts

03.08.2026

Positive

Market Matters Ep. 12: How HIMS Could Benefit From FDA Changes

Press releases

12.08.2026

NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

12.08.2026

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

12.08.2026

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

12.08.2026

Hims & Hers Health, Inc. (HIMS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Hims & Hers Health, Inc. (HIMS)

NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

As Hims prepares for peptides launch, Wall Street cautious on prospects this year

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)

Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Videos

Press releases

NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)

NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

As Hims prepares for peptides launch, Wall Street cautious on prospects this year

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)

Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Videos

Press releases

NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)

Search stocks

Hims & Hers Health, Inc. (HIMS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Hims & Hers Health, Inc. (HIMS)

NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

As Hims prepares for peptides launch, Wall Street cautious on prospects this year

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)

Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Videos

Press releases

NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)

NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

As Hims prepares for peptides launch, Wall Street cautious on prospects this year

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)

Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Videos

Press releases

NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)